FNY Investment Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-600
Closed -$104K 939
2026
Q1
$104K Sell
600
-400
-40% -$82K 0.05% 277
2025
Q4
$256K Hold
1,000
0.07% 203
2025
Q3
$260K Buy
1,000
+500
+100% +$131K 0.08% 241
2025
Q2
$122K Buy
500
+140
+39% +$34.9K 0.05% 276
2025
Q1
$95K Sell
360
-26,900
-99% -$7.28M 0.06% 224
2024
Q4
$6.92M Buy
27,260
+26,856
+6,648% +$7.2M 3.58% 2
2024
Q3
$127K Sell
404
-46
-10% -$16.4K 0.06% 209
2024
Q2
$168K Buy
+450
New +$152K 0.11% 129
2019
Q3
Sell
-700
Closed -$185K 999
2019
Q2
$185K Buy
+700
New +$178K 0.05% 170
2019
Q1
Sell
-200
Closed -$57K 801
2018
Q4
$57K Buy
+200
New +$63.4K 0.02% 223

Other funds holding HUM

FNY Investment Advisers's HUM Position: Q2 2026 in Review

FNY Investment Advisers sold out of Humana (HUM) in Q2 2026, closing a stake of 600 shares — an estimated $104K sold.

FNY Investment Advisers first reported a position in HUM in Q4 2018 and held it in 10 quarters. The position peaked at $6.92M in Q4 2024. 215 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • FNY Investment Advisers reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 600 Humana shares in Q2 2026, an estimated $104K.
  • FNY Investment Advisers first reported a position in Humana in Q4 2018 and held it in 10 quarters.
  • FNY Investment Advisers's Humana position peaked at $6.92M in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.